It is an injectable prescription medicine in the form of a pre-filled pen, which patients use once a week
Common side effects include nausea, vomiting, diarrhea, constipation, abdominal discomfort, fatigue, and headaches especially when first starting or increasing the dose
There was a post-hoc analysis of primary prevention of a multicenter prospective randomized controlled study: Assessing the treatment effect in Metabolic Syndrome Without Perceptible diabetes (ATTEMPT), that included 1123 patients with a mean observation of 4 years that had similar clinical and biochemical benefits with a higher dose of atorvastatin (30 mg per day) in 326 patients who had moderately elevated levels of hepatic enzymes and ultrasonographic findings of NAFLD
These programs are usually based on income and financial need
Despite abundant media coverage on this topic, several factors have not been considered, including the share of prescribed patients with a history of Type 2 diabetes
This is no longer an excuse